MAT2A and kidney disorder: Most prominent and consistent in our dataset and across published datasets from patients, expression of the gene encoding the SAM synthetase, Mat2a, was decreased in injured PTCs that emerge during the course of kidney disease triggered by metabolic stress (e.g., HFD) compared with other PTCs.